Taipei Exchange - Delayed Quote TWD

Han Biomedical (6999.TWO)

41.20
0.00
(0.00%)
At close: 1:02:56 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
115,303
115,303
96,842
93,984
83,348
Cost of Revenue
30,243
30,243
26,384
33,387
31,486
Gross Profit
85,060
85,060
70,458
60,597
51,862
Operating Expense
57,417
57,417
45,022
36,813
35,494
Operating Income
27,643
27,643
25,436
23,784
16,368
Net Non Operating Interest Income Expense
1,801
1,801
1,186
-74
-250
Pretax Income
30,872
30,872
27,132
24,209
16,435
Tax Provision
6,590
6,590
5,590
5,467
4,296
Net Income Common Stockholders
24,282
24,282
21,542
18,742
12,139
Diluted NI Available to Com Stockholders
24,282
24,282
21,542
18,742
12,139
Basic EPS
1.31
--
1.19
1.05
0.76
Diluted EPS
1.31
--
1.19
1.04
0.76
Basic Average Shares
18,535.88
--
18,102.52
17,907.89
15,896.21
Diluted Average Shares
18,535.88
--
18,102.52
17,935.13
15,896.21
Total Expenses
87,660
87,660
71,406
70,200
66,980
Net Income from Continuing & Discontinued Operation
24,282
24,282
21,542
18,742
12,139
Normalized Income
24,282
24,282
21,542
18,742
12,139
Interest Income
1,870
1,870
1,320
132
14
Interest Expense
69
69
134
206
264
Net Interest Income
1,801
1,801
1,186
-74
-250
EBIT
30,941
30,941
27,266
24,415
16,699
EBITDA
42,136
42,136
39,875
40,568
34,893
Reconciled Cost of Revenue
30,243
30,243
26,384
33,387
31,486
Reconciled Depreciation
11,195
11,195
12,609
16,153
18,194
Net Income from Continuing Operation Net Minority Interest
24,282
24,282
21,542
18,742
12,139
Normalized EBITDA
42,136
42,136
39,875
40,568
34,893
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/31/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers